Updated:
RedSail Technologies
RedSail Technologies is a Spartanburg-based firm with an undisclosed investment mandate and no public ownership or AUM data.
RedSail Technologies
RedSail Technologies specializes in pharmacy software and solutions for the healthcare sector. The company provides pharmacy management systems, workflow and delivery software, and transaction processing services. It serves community and long-term care pharmacies, outpatient and clinic pharmacies, and pharma and strategic industry partners.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Spartanburg
Corporate office
Spartanburg, SC, United States
Frequently asked questions
Who controls RedSail Technologies?
The beneficial ownership of RedSail Technologies is not publicly disclosed. No named individuals or family groups have been associated with the firm in public records or credible media reports.
Does RedSail Technologies invest directly, through funds, or both?
RedSail Technologies has not publicly described its investment approach. There is no confirmed evidence of direct investments, fund commitments, or any other deployment mechanism.
What sectors does RedSail Technologies focus on?
No sector focus has been identified for RedSail Technologies. Public sources do not reference any specific industries, asset classes, or thematic areas.
How large is RedSail Technologies?
The firm does not disclose assets under management, capital deployment, or organizational headcount. Its scale remains unknown, and no external estimates are available.
Where does the capital backing RedSail Technologies originate?
The origin of the firm's capital is not publicly known. No wealth source—whether from a single family, institution, or other entity—has been disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: